Table 1.
Cancer patients, n (%) |
Fibroadenoma patients, n (%) |
|||||
---|---|---|---|---|---|---|
rs1271572 | ERβ–positive | ERβ–negative | pvalue | ERβ–positive | ERβ–negative | pvalue |
GG |
226 (26.43) |
39 (4.56) |
|
205 (32.64) |
30 (4.78) |
|
GT |
350 (40.94) |
60 (7.02) |
<0.001 |
266 (42.36) |
38 (6.05) |
0.93 |
TT |
122 (14.27) |
58 (6.78) |
|
79 (12.58) |
10 (1.59) |
|
GG |
226 (26.43) |
39 (4.56) |
|
205 (32.64) |
30 (4.78) |
|
GT+TT(T carrier) | 472 (55.20) | 118 (13.80) | 0.07 | 345 (54.94) | 48 (7.64) | 0.901 |